Answers are grounded in this paper and cite their sources.
The attempt to speed up drug registration approvals could be detrimental for the appropriateness and safety of new medicines in Australia.
No takes yet. Share an insight, caveat, or question.
Martin et al. (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: